Download the quick ASDAS-CRP calculation form - ASAS

Download the quick ASDAS-CRP calculation form - ASAS

Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study

Full article: Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational study

ASDAS Calculator

The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology

ASDAS Calculator, PDF, Back Pain

ASDAS Calculator

PDF) ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis

FRI0194 Ankylosing spondylitis disease activity score (ASDAS) based on a quick quantitative crp assay performs similarly well to asdas based on conventional crp in patients with axial spondyloarthritis

Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies

Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5

Assessment and Monitoring, Ankylosing Spondylitis

Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care.

Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis – topic of research paper in

Metallothionein 1